Considerations for the Lifetime Management of the Patient With RVOT Dysfunction: How I Stage the Approach for Optimal Outcome
Presenter
Nathan W. Taggart, M.D., FSCAI, Mayo Clinic, Rochester, MN
Nathan W. Taggart, M.D., FSCAI, Mayo Clinic, Rochester, MN
Learning Objectives:
- Describe the considerations for lifetime management of patient with an RV to PA conduit or BPV: How to best stage a patient to minimize the number of interventions while maintaining the health of the RV
- Describe the considerations for lifetime management of a patient with a “native” outflow tract: How to best stage a patient to minimize the number of interventions while maintaining the health of the RV
- Describe differences between the Harmony or Alterra that will impact future interventions on these devices.
Keywords: Congenital Heart Disease (CHD), Right Ventricular Outflow Tract (RVOT) and TPVR/Pulmonary Valve